Paolo Manzoni

Alan Lucas

 

Paolo Manzoni, MD

Paolo Manzoni, MD, PhD, has been for the last 12 years coordinator of the Study Group for Neonatal Fungal Infections, affiliated to the Italian Society of Neonatology in Italy.
Since 1012, he is also the Coordinator of the Neonatology Network of the Clinical Trial Center based in Rome, at the OPBG Hospital - Catholic University.

Dr Manzoni earned his medical degree and specialization in Pediatrics from the University of Torino School of Medicine in 1989 and 1993, respectively, and conducted his residency in pediatric pulmonology and fellowship in infectious diseases and immunology at Azienda Ospedaliera OIRM - Sant'Anna of Torino from 1991 to 1995, when he became part of the Faculty Staff of the Division of Neonatology and NICU at the same Institution.

Dr Manzoni is on the Board of Directors for the Italian Society of Neonatology, Board of Editors for the Italian Society of Neonatal Infectious Diseases, and an associate member of the American Society for Pediatric Research and the Italian Society of Neonatology.
He is also an external consultant for Pediatrics and Neonatology for the Italian Drug Agency (AIFA) and for the Pediatric Committee at the EMA (Europe Medicine Agency) .
He is also co-founder of the Charity and Scientific Foundation "Crescere insieme al Sant'Anna".

Dr Manzoni's primary research interests include pediatric and neonatal infectious diseases, fungal infections and prevention, RSV related diseases, retinopathy of prematurity, and neonatal nutrition. He was the leading investigator of the first, multicenter clinical trial of prophylactic fluconazole in preterm neonates, as well as of the first international, multicenter clinical trial of probiotic and lactoferrin feeding in preterm neonates.
He is the leading investigator of an ongoing European project on fluconazole and ciprofloxacin in neonates funded by the European Union in accordance with the European Medicine Agency (EMA), acting as WP leader in the TINN consortium; he is also involved in several other EU-funded research consortiums devoted to the study of antimicrobial drugs for neonates (NeoMero, Neovanc, etc).
He is the author of approximately 150 research articles published in peer-reviewed Italian and international medical journals, and Editor/Associate Editor of a number of peer-reviewed, leading international Journals..

Paolo Manzoni, MD, is the chairman of the GSIN- Collaborative Network on Neonatal Infections of the Italian Society of Neonatology in Italy. Dr Manzoni earned his medical degree and specialization in Pediatrics from the University of Torino School of Medicine in 1989 and 1993, respectively, and conducted his residency in pediatric pulmonology and fellowship in infectious diseases and immunology at Azienda Ospedaliera OIRM - Sant'Anna of Torino from 1991 to 1995, when he became part of the Faculty Staff of the Division of Neonatology and NICU at the same Institution. Dr Manzoni is on the Board of Directors for the Italian Society of Pediatrics, Council Deputy Secretary of the World Association of Perinatal Medicine (WAPM), a founding member of the RESVINET scientific network of experts on RSV, and an associate member of the American Society for Pediatric Research and the Italian Society of Neonatology. He is also on the Board of Pediatric Consultants of the Italian Drug Agency (AIFA) . He is also co-founder of the Charity and Scientific Foundation "Crescere insieme al Sant'Anna". Dr Manzoni's primary research interests include pediatric and neonatal infectious diseases, RSV related diseases, retinopathy of prematurity, and neonatal nutrition. He was the leading investigator of the first, multicenter clinical trial of prophylactic fluconazole in preterm neonates, as well as of the first international, multicenter clinical trial of probiotic and lactoferrin feeding in preterm neonates. He is the leading investigator of an ongoing European project on fluconazole and ciprofloxacin in neonates funded by the European Union in accordance with the European Medicine Agency (EMEA), acting as WP leader in the TINN consortium. He serves as Associate Editor for a number of prestigious international scientific Journals, and is the author of approximately 140 research articles published in peer-reviewed Italian and international medical journals.